Zobrazeno 1 - 1
of 1
pro vyhledávání: '"DO Pavel Kibrik"'
Publikováno v:
Osteopathic Family Physician. :40-43
Introduction: Inhibitors of programmed cell death receptor (PD-1) and its ligand (PD-L1), such as nivolumab and pembrolizumab, confer anti-autoimmune activities and are therefore approved for anti-cancer therapy. Their mode of action removes autoimmu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a3026cd327d3844bd74981e3b3b8f6
https://doi.org/10.33181/13037
https://doi.org/10.33181/13037
